DCTH — DELCATH SYSTEMS, INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 872912 ·
Last close
$13.01
Market Cap
$449.13M
52W High
$13.74
52W Low
$9.96
ADV30
544,686
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 24,994,000 | 21,258,000 | -1,637,000 | -1,070,000 | 124,838,000 | 41,313,000 | 12,128,000 |
| Dec 2025 | 20,728,000 | 17,718,000 | -2,184,000 | -1,896,000 | 123,632,000 | 43,454,000 | 12,413,000 |
| Sep 2025 | 20,563,000 | 17,939,000 | -388,000 | 830,000 | 124,295,000 | 41,813,000 | 9,448,000 |
| Jun 2025 | 24,156,000 | 20,838,000 | 2,590,000 | 2,697,000 | 116,876,000 | 34,421,000 | 11,890,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$22,516,000
Investing CF
$-26,590,000
Financing CF
$15,048,000
CapEx
$-1,547,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.07
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-528,848,000
Inventory
$10,252,000
Receivables
$12,939,000
ST Investments
$47,582,000
EBIT TTM
$660,000
Pretax Income TTM
$3,510,000
Interest Exp TTM
—
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$90,441,000
EBITDA
$-1,322,000
Free Cash Flow
$19,651,124
Enterprise Value
$378,340,672
Total Cash
$89,299,000
Total Debt
$907,000
Shares Out
34,521,647
Trailing EPS
$0.01
Book Value
$3.27
ROE
0.6%
ROA
-1.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 85,231,000 | 660,000 | 2,700,000 | 123,632,000 | 12,413,000 | — | 22,516,000 |
| Dec 2024 | 37,205,000 | -12,410,000 | -26,386,000 | 76,589,000 | 7,843,000 | — | -18,681,000 |
| Dec 2023 | 2,065,000 | -38,182,000 | -47,678,000 | 38,613,000 | 22,836,000 | — | -31,251,000 |
| Dec 2022 | 2,719,000 | -33,853,000 | -36,508,000 | 17,862,000 | 23,721,000 | — | -24,950,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.51
Max Pain — expiry 2026-08-21
max pain strike: $10.00 · spot: $13.01 · call oi: 1,833 · put oi: 238
Expected Move to 2026-08-21:
±$2.92
(22.48%) —
implied range
$10.09 –
$15.94
· ATM straddle on $12.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| OFIX | Orthofix Medical Inc. | $470.10M | $11.63 | — |
| SI | SHOULDER INNOVATIONS, INC. | $418.08M | $20.16 | — |
| MOBI | Mobia Medical, Inc. | $405.31M | $12.19 | — |
| KIDS | ORTHOPEDIATRICS CORP | $522.18M | $20.33 | — |
| CLPT | ClearPoint Neuro, Inc. | $524.82M | $17.50 | — |
News headlines (Yahoo Finance, 1h cache)
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer
2026-07-09 12:00 · Yahoo
Delcath (DCTH) Q1 2026 Earnings Transcript
2026-05-08 16:25 · Yahoo
Delcath Systems Q1 Earnings Call Highlights
2026-05-07 17:42 · Yahoo
Delcath Systems, Inc. (DCTH) Reports Q1 Loss, Misses Revenue Estimates
2026-05-07 15:15 · Yahoo
How The Delcath Systems (DCTH) Story Is Shifting With Hepzato Milestones And 2026 Guidance
2026-05-01 09:20 · Yahoo
Implied Volatility Surging for Delcath Systems Stock Options
2026-04-07 14:06 · Yahoo
Delcath Systems publishes results from CHOPIN trial in The Lancet Oncology
2026-03-04 13:43 · Yahoo
Delcath Systems Inc (DCTH) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ...
2026-02-26 21:09 · Yahoo
Delcath Systems Q4 Earnings Call Highlights
2026-02-26 20:48 · Yahoo
Delcath (DCTH) Q4 2025 Earnings Call Transcript
2026-02-26 15:33 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.